IYVAX Fees and Costs — Delaware Ivy Value Fund, Class A
Data updated: 2024-08-27
The net expense ratio is 1.08%: a 0.69% management fee, a 0.25% 12b-1 fee plus 0.20% other expenses, less a 0.06% fee waiver. This share class carries a maximum front-end sales load of 5.75%. In fiscal 2024 the fund paid $167K in broker commissions, 0.0291% of average net assets, and portfolio turnover was 103%.
IYVAX Fees and Expenses
Annual operating expenses and sales charges of IYVAX. Prospectus, as of March 31, 2023.
| Annual operating expenses | |
|---|---|
| Management fee | 0.69% |
| 12b-1 fee | 0.25% |
| Other expenses | 0.20% |
| Gross expense ratio | 1.14% |
| Fee waiver | −0.06% |
| Net expense ratio | 1.08% |
| Sales charges | |
|---|---|
| Max front load | 5.75% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
IYVAX Costs Over Time
On $10,000 invested in IYVAX, assuming 5% a year before costs, total costs come to $1,386 over 5 years, cutting the return by 2.39% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $575 | $575 | $575 |
| Fund expenses (net expense ratio 1.08%) | $107 | $333 | $577 |
| Trading costs (broker commissions) | $3 | $9 | $16 |
| Lost growth on money paid in costs | $29 | $108 | $219 |
| Total costs | $714 | $1,025 | $1,386 |
| Value after costs | $9,786 | $10,552 | $11,377 |
| Impact on return, per year | 7.14% | 3.19% | 2.39% |
IYVAX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending March 31, 2024.
- Explicit cost rate (commissions ÷ average net assets): 0.0291%
- Total broker commissions: $167K
- Bought from dealers (principal trades, not a cost): —
- Portfolio turnover (prospectus): 103%
- Securities lending: none during the year
IYVAX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| MORGAN STANLEY & CO. LLC | $27K | 19.93% |
| J.P. Morgan Securities LLC | $21K | 15.24% |
| GOLDMAN SACHS & CO. LLC | $18K | 12.84% |
| BARCLAYS CAPITAL, INC. | $13K | 9.41% |
| BOFA SECURITIES, INC. | $13K | 9.40% |
| CitiGroup Global Markets Inc. | $12K | 8.97% |
| UBS Securities LLC | $10K | 7.30% |
| EVERCORE GROUP LLC | $8K | 6.17% |
| JEFFERIES LLC | $8K | 5.69% |
| RBC CAPITAL MARKETS, LLC | $7K | 5.05% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.